Erratum

Ofatumumab, a novel CD20 monoclonal antibody, is active in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia irrespective of prior rituximab (Clinical lymphoma & Myeloma (2009) 9: 6 (E36) DOI: 10.3816/CLM.2009.n.098)

William G Wierda, Thomas Kipps, Jiří Mayer, Stephan Stilgenbauer, Cathy D. Williams, Andrzej Hellmann, Tadeusz Robak, Richard R. Furman, Peter Hillmen, Marek Trneny, Martin J.S. Dyer, Swaminathan Padmanabhan Iyer, Magdalena Piotrowska, Tomas Kozak, Geoffrey Chan, Randy Davis, Nedjad Losic, Joris Wilms, Charlotte Russell, Anders Österborg

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalClinical Lymphoma, Myeloma and Leukemia
Volume10
Issue number2
DOIs
StatePublished - Jan 1 2010

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Lymphoma
Monoclonal Antibodies
Rituximab
alemtuzumab
fludarabine
ofatumumab

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Erratum : Ofatumumab, a novel CD20 monoclonal antibody, is active in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia irrespective of prior rituximab (Clinical lymphoma & Myeloma (2009) 9: 6 (E36) DOI: 10.3816/CLM.2009.n.098). / Wierda, William G; Kipps, Thomas; Mayer, Jiří; Stilgenbauer, Stephan; Williams, Cathy D.; Hellmann, Andrzej; Robak, Tadeusz; Furman, Richard R.; Hillmen, Peter; Trneny, Marek; Dyer, Martin J.S.; Iyer, Swaminathan Padmanabhan; Piotrowska, Magdalena; Kozak, Tomas; Chan, Geoffrey; Davis, Randy; Losic, Nedjad; Wilms, Joris; Russell, Charlotte; Österborg, Anders.

In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 10, No. 2, 01.01.2010.

Research output: Contribution to journalComment/debate

Wierda, William G ; Kipps, Thomas ; Mayer, Jiří ; Stilgenbauer, Stephan ; Williams, Cathy D. ; Hellmann, Andrzej ; Robak, Tadeusz ; Furman, Richard R. ; Hillmen, Peter ; Trneny, Marek ; Dyer, Martin J.S. ; Iyer, Swaminathan Padmanabhan ; Piotrowska, Magdalena ; Kozak, Tomas ; Chan, Geoffrey ; Davis, Randy ; Losic, Nedjad ; Wilms, Joris ; Russell, Charlotte ; Österborg, Anders. / Erratum : Ofatumumab, a novel CD20 monoclonal antibody, is active in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia irrespective of prior rituximab (Clinical lymphoma & Myeloma (2009) 9: 6 (E36) DOI: 10.3816/CLM.2009.n.098). In: Clinical Lymphoma, Myeloma and Leukemia. 2010 ; Vol. 10, No. 2.
@article{cb630f50236940a8bd6c717016adfa89,
title = "Erratum: Ofatumumab, a novel CD20 monoclonal antibody, is active in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia irrespective of prior rituximab (Clinical lymphoma & Myeloma (2009) 9: 6 (E36) DOI: 10.3816/CLM.2009.n.098)",
author = "Wierda, {William G} and Thomas Kipps and Jiř{\'i} Mayer and Stephan Stilgenbauer and Williams, {Cathy D.} and Andrzej Hellmann and Tadeusz Robak and Furman, {Richard R.} and Peter Hillmen and Marek Trneny and Dyer, {Martin J.S.} and Iyer, {Swaminathan Padmanabhan} and Magdalena Piotrowska and Tomas Kozak and Geoffrey Chan and Randy Davis and Nedjad Losic and Joris Wilms and Charlotte Russell and Anders {\"O}sterborg",
year = "2010",
month = "1",
day = "1",
doi = "10.3816/CLML.2010.n.024",
language = "English (US)",
volume = "10",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2669",
publisher = "Cancer Media Group",
number = "2",

}

TY - JOUR

T1 - Erratum

T2 - Ofatumumab, a novel CD20 monoclonal antibody, is active in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia irrespective of prior rituximab (Clinical lymphoma & Myeloma (2009) 9: 6 (E36) DOI: 10.3816/CLM.2009.n.098)

AU - Wierda, William G

AU - Kipps, Thomas

AU - Mayer, Jiří

AU - Stilgenbauer, Stephan

AU - Williams, Cathy D.

AU - Hellmann, Andrzej

AU - Robak, Tadeusz

AU - Furman, Richard R.

AU - Hillmen, Peter

AU - Trneny, Marek

AU - Dyer, Martin J.S.

AU - Iyer, Swaminathan Padmanabhan

AU - Piotrowska, Magdalena

AU - Kozak, Tomas

AU - Chan, Geoffrey

AU - Davis, Randy

AU - Losic, Nedjad

AU - Wilms, Joris

AU - Russell, Charlotte

AU - Österborg, Anders

PY - 2010/1/1

Y1 - 2010/1/1

UR - http://www.scopus.com/inward/record.url?scp=84860605156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860605156&partnerID=8YFLogxK

U2 - 10.3816/CLML.2010.n.024

DO - 10.3816/CLML.2010.n.024

M3 - Comment/debate

VL - 10

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2669

IS - 2

ER -